Skip to main content
HCP Education

Reach the physicians already making the decision

Sequence education by real clinical signals like biomarker results, progression indicators or treatment patterns, across an entire network.

Biomarker testing, staging and line of therapy form clinical signals. OncoLens AI turns them into signal-directed education, the right message at the right moment for specific patient populations and physician behavior, delivered through agency activation, platform alerts and HCP email campaigns.

How OncoLens helps

Four ways education reaches the physician at the moment it matters.

Timing

Direct-to-cancer-center alerts and triggers

  • Outreach lands while there is room to assist provider and patient, not after
  • An EMR-based signal puts a decision in front of a physician
Presence

Aligned to cancer center and HCP needs

  • Aligned with cancer center preferences
  • Within the tumor board, EMR alerts, HCP emails or education channel partners
  • Education reaches the full care team, not only the individual physician
Sequencing

Omnichannel education across the lifecycle

  • Data-driven and targeted, phase by phase
  • Awareness building before launch
  • Adoption support at launch
  • Reinforcement after launch
Scale

Cancer center engagement handled by OncoLens

  • Your team grows its reach without growing its headcount
  • OncoLens engages cancer centers directly
  • Sales teams scale without added headcount
County-level map showing where patients under care in the OncoLens network are concentrated across the United States, with Alaska and Hawaii shown as insets
Where patients under care are concentrated
225+U.S.-based cancer center locations
6,000,000+patients under care
90%community-based
88%AI-extracted insights

Frequently asked questions

What does HCP education mean as an OncoLens solution?

OncoLens delivers targeted, data-driven education to physicians and cancer centers, using EMR-based clinical signals to determine which HCPs need which information and when. Rather than broad, undifferentiated outreach, education is directed at the physicians and centers most relevant to a given treatment or testing pathway at that moment.

How is this education sequenced across a product’s lifecycle?

OncoLens structures HCP education across pre-launch, launch, and post-launch phases, adjusting the content and cadence of outreach as a therapy or testing approach moves through its lifecycle. This ensures physicians receive the right information, awareness-building early, adoption support at launch, reinforcement post-launch, rather than a single static campaign.

How does OncoLens get in front of oncologists beyond traditional rep visits or conferences?

OncoLens engages HCPs directly through channels like tumor boards and e-consults, in addition to data-driven omnichannel marketing and education. This gives life sciences teams a presence inside the actual clinical decision-making moments physicians participate in, not just adjacent marketing touchpoints.

How does OncoLens engage cancer centers as institutions, not just individual physicians?

OncoLens works directly with cancer centers, including participating in tumor board discussions and e-consults, so education and engagement reach the full care team involved in a treatment decision. This institutional-level engagement complements physician-level outreach rather than replacing it.

What makes OncoLens’s education data-driven rather than a generic communications program?

Education is directed by EMR-based signals, including biomarker results and treatment or progression indicators, that identify which physicians and cancer centers are actively managing relevant patients. That grounding in real clinical activity, rather than static targeting lists, is what keeps the education timely and relevant to where a physician actually is in a patient’s care.

Get in touch

Bring education into the workflow

Cover your education needs across 15% of the U.S. provider market.